ISIN
PLPRBLG00010
Ticker
PUR
Sector
Sub-Industry
Country
Poland
Year Founded
2010
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.
Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.
Worldwide
PLPRBLG00010
2594002TXS19AUYHIF82
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.